ArticleTherapeutic advances in musculoskeletal diseasePublished
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib study
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Therapeutic advances in musculoskeletal disease
- Published
- Topic
- Clinical care
- Subject terms
- Rheumatoid arthritis; Programmed Cell Death Protein 1
- PubMed ID
- 41146691
- PubMed Central ID
- PMC12553887
- Open access
- Yes, open
- Added to directory
- Source checked